Aimco Pesticides Limited (BOM:524288)
48.00
-1.18 (-2.40%)
At close: Mar 9, 2026
Aimco Pesticides Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,762 | 1,977 | 2,072 | 2,062 | 3,120 | 1,757 | Upgrade
|
| Other Revenue | 3.42 | 5.61 | 1.91 | 4.83 | 6.75 | 24.14 | Upgrade
|
| Revenue | 1,765 | 1,982 | 2,074 | 2,067 | 3,127 | 1,781 | Upgrade
|
| Revenue Growth (YoY) | -3.19% | -4.43% | 0.35% | -33.90% | 75.55% | -5.66% | Upgrade
|
| Cost of Revenue | 1,437 | 1,546 | 1,744 | 1,614 | 2,482 | 1,390 | Upgrade
|
| Gross Profit | 328.42 | 436.35 | 330.43 | 453.2 | 645.06 | 390.7 | Upgrade
|
| Selling, General & Admin | 189.26 | 187.82 | 186.57 | 149.78 | 106.64 | 94.38 | Upgrade
|
| Other Operating Expenses | 246.29 | 268.44 | 215.21 | 269.74 | 349.34 | 204.27 | Upgrade
|
| Operating Expenses | 470.1 | 496.95 | 444.47 | 455.62 | 483.39 | 320.62 | Upgrade
|
| Operating Income | -141.69 | -60.61 | -114.05 | -2.42 | 161.67 | 70.09 | Upgrade
|
| Interest Expense | -27.34 | -30.94 | -26.45 | -24.05 | -14.74 | -43.89 | Upgrade
|
| Interest & Investment Income | 0.48 | 0.48 | 1.31 | 0.45 | 0.32 | 0.61 | Upgrade
|
| Currency Exchange Gain (Loss) | -10.75 | -10.75 | -3.54 | -7.59 | -3.11 | 3.57 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.63 | 5.91 | 9.45 | 4.36 | 1 | 2.07 | Upgrade
|
| EBT Excluding Unusual Items | -171.67 | -95.9 | -133.26 | -29.26 | 145.15 | 32.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | 0 | 0.01 | 0.67 | 0.31 | 0.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.61 | -0.27 | -0.06 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.57 | Upgrade
|
| Pretax Income | -171.66 | -95.9 | -133.25 | -27.98 | 145.19 | 31.94 | Upgrade
|
| Income Tax Expense | -39.78 | -23.47 | -32.79 | -6.12 | 38.59 | 10.95 | Upgrade
|
| Net Income | -131.89 | -72.43 | -100.46 | -21.85 | 106.6 | 21 | Upgrade
|
| Net Income to Common | -131.89 | -72.43 | -100.46 | -21.85 | 106.6 | 21 | Upgrade
|
| Net Income Growth | - | - | - | - | 407.72% | -68.41% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 0.33% | 0.15% | - | - | - | 0.07% | Upgrade
|
| EPS (Basic) | -13.73 | -7.55 | -10.48 | -2.28 | 11.12 | 2.19 | Upgrade
|
| EPS (Diluted) | -13.73 | -7.55 | -10.48 | -2.28 | 11.12 | 2.19 | Upgrade
|
| EPS Growth | - | - | - | - | 407.72% | -68.43% | Upgrade
|
| Free Cash Flow | - | 14.84 | 20.25 | -167.6 | 147.86 | 36.34 | Upgrade
|
| Free Cash Flow Per Share | - | 1.55 | 2.11 | -17.49 | 15.43 | 3.79 | Upgrade
|
| Dividend Per Share | - | - | - | 1.000 | 2.000 | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | -50.00% | 100.00% | -33.33% | Upgrade
|
| Gross Margin | 18.60% | 22.01% | 15.93% | 21.93% | 20.63% | 21.94% | Upgrade
|
| Operating Margin | -8.03% | -3.06% | -5.50% | -0.12% | 5.17% | 3.94% | Upgrade
|
| Profit Margin | -7.47% | -3.65% | -4.84% | -1.06% | 3.41% | 1.18% | Upgrade
|
| Free Cash Flow Margin | - | 0.75% | 0.98% | -8.11% | 4.73% | 2.04% | Upgrade
|
| EBITDA | -103.68 | -21.28 | -72.98 | 33.33 | 183.19 | 86.31 | Upgrade
|
| EBITDA Margin | -5.87% | -1.07% | -3.52% | 1.61% | 5.86% | 4.85% | Upgrade
|
| D&A For EBITDA | 38.01 | 39.32 | 41.07 | 35.76 | 21.51 | 16.23 | Upgrade
|
| EBIT | -141.69 | -60.61 | -114.05 | -2.42 | 161.67 | 70.09 | Upgrade
|
| EBIT Margin | -8.03% | -3.06% | -5.50% | -0.12% | 5.17% | 3.94% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 26.58% | 34.28% | Upgrade
|
| Revenue as Reported | 1,774 | 1,989 | 2,085 | 2,073 | 3,128 | 1,787 | Upgrade
|
| Advertising Expenses | - | 26.62 | 24.76 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.